Citi Starts Larimar Therapeutics (LRMR) at Neutral
Get Alerts LRMR Hot Sheet
Price: $4.34 +0.70%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
Citi analyst Samantha Semenkow initiates coverage on Larimar Therapeutics (NASDAQ: LRMR) with a Neutral rating and a price target of $4.00.
For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.
Shares of Larimar Therapeutics closed at $3.89 yesterday.
You May Also Be Interested In
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
- Macquarie Starts ISC (095340:KS) at Outperform
- Piper Sandler Starts LightPath Technologies (LPTH) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share